{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T05:04:03Z","timestamp":1771909443777,"version":"3.50.1"},"reference-count":40,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NDT"],"DOI":"10.2147\/ndt.s376104","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T09:50:06Z","timestamp":1666691406000},"page":"2431-2441","source":"Crossref","is-referenced-by-count":9,"title":["Implications of Seizure-Cluster Treatment on Healthcare Utilization: Use of Approved Rescue Medications"],"prefix":"10.2147","volume":"Volume 18","author":[{"given":"Adrian L","family":"Rabinowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7415-8044","authenticated-orcid":true,"given":"Edward","family":"Faught","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8788-0722","authenticated-orcid":true,"given":"Enrique","family":"Carrazana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"821","DOI":"10.15585\/mmwr.mm6631a1","volume":"66","author":"Zack","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1111\/epi.17305","volume":"63","author":"Moura","year":"2022","journal-title":"Epilepsia"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.seizure.2018.05.013","volume":"68","author":"Jafarpour","year":"2019","journal-title":"Seizure"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/epi.14479","volume":"59","author":"Maglalang","year":"2018","journal-title":"Epilepsia"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.yebeh.2015.04.022","volume":"47","author":"Fisher","year":"2015","journal-title":"Epilepsy Behav"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/NRL.0000000000000140","volume":"22","author":"Penovich","year":"2017","journal-title":"Neurologist"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/jamaneurol.2020.5370","volume":"78","author":"Leguia","year":"2021","journal-title":"JAMA Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/WCO.0000000000000177","volume":"28","author":"Haut","year":"2015","journal-title":"Curr Opin Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/epi.16449","volume":"61","author":"Hogan","year":"2020","journal-title":"Epilepsia"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/epi.16847","volume":"62","author":"Cloyd","year":"2021","journal-title":"Epilepsia"},{"key":"ref11","unstructured":"Epilepsy Foundation. FDA news: Nayzilam (midazolam) nasal spray approved for seizure clusters. Available from: https:\/\/www.epilepsy.com\/article\/2019\/5\/fda-news-nayzilam-midazolam-nasal-spray-approved-seizure-clusters. Accessed March 16, 2021."},{"key":"ref12","unstructured":"Epilepsy Foundation. New drug: Valtoco (diazepam nasal spray) approved as rescue therapy for seizures. Available from: https:\/\/www.epilepsy.com\/article\/2020\/1\/new-drug-valtoco-diazepam-nasal-spray-approved-rescue-therapy-seizures. Accessed March 16, 2021."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/epi.13084","volume":"56","author":"Begley","year":"2015","journal-title":"Epilepsia"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.yebeh.2013.09.046","volume":"31","author":"Cramer","year":"2014","journal-title":"Epilepsy Behav"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.yebeh.2014.01.016","volume":"32","author":"Cramer","year":"2014","journal-title":"Epilepsy Behav"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/j.1528-1157.1999.tb02047.x","volume":"40","author":"Mitchell","year":"1999","journal-title":"Epilepsia"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1111\/epi.17041","volume":"62","author":"Wheless","year":"2021","journal-title":"Epilepsia"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1111\/epi.16300","volume":"60","author":"Wheless","year":"2019","journal-title":"Epilepsia"},{"key":"ref20","unstructured":"Diastat\u00ae C-IV (diazepam rectal gel) [prescribing information]. Bridgewater, NJ: Bausch Health US, LLC; 2021."},{"key":"ref21","unstructured":"NAYZILAM\u00ae (midazolam nasal spray) [prescribing information]. Smyrna, GA: UCB, Inc; 2021."},{"key":"ref22","unstructured":"VALTOCO\u00ae (diazepam nasal spray) [prescribing information]. San Diego, CA: Neurelis, Inc; 2022."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.eplepsyres.2013.02.018","volume":"105","author":"Agarwal","year":"2013","journal-title":"Epilepsy Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1056\/NEJM199806253382602","volume":"338","author":"Dreifuss","year":"1998","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1111\/epi.15159","volume":"60","author":"Detyniecki","year":"2019","journal-title":"Epilepsia"},{"key":"ref26","unstructured":"US Food and Drug Administration. Clinical superiority findings. Available from: https:\/\/www.fda.gov\/industry\/designating-orphan-product-drugs-and-biological-products\/clinical-superiority-findings. Accessed June 23, 2020."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/epi.16901","volume":"62","author":"Segal","year":"2021","journal-title":"Epilepsia"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/epi.17177","volume":"63","author":"Sperling","year":"2022","journal-title":"Epilepsia"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1111\/epi.17249","volume":"63","author":"Cascino","year":"2022","journal-title":"Epilepsia"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2022.04.011","volume":"132","author":"Tarquinio","year":"2022","journal-title":"Pediatr Neurol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/epi4.12494","volume":"6","author":"Miller","year":"2021","journal-title":"Epilepsia Open"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"107898","DOI":"10.1016\/j.yebeh.2021.107898","volume":"118","author":"Vazquez","year":"2021","journal-title":"Epilepsy Behav"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.eplepsyres.2010.10.001","volume":"93","author":"Garnett","year":"2011","journal-title":"Epilepsy Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"108013","DOI":"10.1016\/j.yebeh.2021.108013","volume":"121","author":"Penovich","year":"2021","journal-title":"Epilepsy Behav"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1080\/14737175.2021.1965880","volume":"21","author":"Higdon","year":"2021","journal-title":"Expert Rev Neurother"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/epi.16506","volume":"61","author":"Hogan","year":"2020","journal-title":"Epilepsia"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"AB77","DOI":"10.1016\/j.jaci.2019.12.668","volume":"145","author":"Tanimoto","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s40268-021-00360-5","volume":"21","author":"Rabinowicz","year":"2021","journal-title":"Drugs R D"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"107836","DOI":"10.1016\/j.yebeh.2021.107836","volume":"117","author":"Buchhalter","year":"2021","journal-title":"Epilepsy Behav"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/epi.17237","volume":"63","author":"Wirrell","year":"2022","journal-title":"Epilepsia"}],"container-title":["Neuropsychiatric Disease and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=84930","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=84930","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T09:50:11Z","timestamp":1666691411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/implications-of-seizure-cluster-treatment-on-healthcare-utilization-us-peer-reviewed-fulltext-article-NDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":40,"URL":"https:\/\/doi.org\/10.2147\/ndt.s376104","relation":{},"ISSN":["1178-2021"],"issn-type":[{"value":"1178-2021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}